A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the CDC still failed to “reliably meet ...

President Donald Trump's nominee for U.S. surgeon general, Dr. Casey Means, has appeared on numerous wellness and right-wing ...

President Donald Trump's pick for surgeon general, wellness influencer and Robert F. Kennedy Jr.-ally Casey Means, is big ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

The Department of Health and Human Services' mass dismissals of workers who release government records "raise grave transparency, accountability, and privacy concerns," Oregon Sen. Ron Wyden said ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...